Viatris (VTRS) Earnings Date & Reports

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

VTRS is expected to report earnings to rise 9.76% to 54 cents per share on August 11

Q2'25

Est.

$0.55

Q1'25

Missed

by $0.01

Q4'24

Missed

by $0.04

Q3'24

Beat

by $0.07

Q2'24

Beat

by $0.01

The last earnings report on May 08 showed earnings per share of 50 cents, missing the estimate of 50 cents. With 19.14M shares outstanding, the current market capitalization sits at 14.18B.

View a ticker or compare two or three

Compare

VTRS